Analytical Data
-
基因名
E1
- Application
-
别名
ATP-dependent helicase E1
-
种属
Human papillomavirus type 11
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P04014
-
表达区间
452-602aa
-
分子量
23.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
E1 recombinant protein, specifically related to the E1 enzyme of viruses, is a significant focus in biomedical research due to its critical role in viral replication and assembly. It serves as a pivotal component in the life cycle of various viruses, including those that cause serious diseases in humans and animals. The study of E1 recombinant proteins facilitates a deeper understanding of virus-host interactions and can provide insights into potential therapeutic targets. For instance, in the context of alphaviruses, the E1 protein is essential for membrane fusion and entry into host cells, making it a prime candidate for vaccine development and antiviral strategies. Researchers have been able to produce E1 proteins using recombinant DNA technology, allowing for the analysis of their structure and function in detail. Such studies have the potential to aid in the design of vaccines that elicit strong immune responses or in the development of inhibitors that disrupt viral life cycles, thereby mitigating the impacts of viral infections. Additionally, understanding the immunogenic properties of E1 proteins is crucial for the development of diagnostic tools and therapeutic agents. As global health concerns continue to rise, particularly in the context of emerging infectious diseases, research into E1 recombinant proteins remains a vital area of investigation for combating viral threats and enhancing public health safety.
